Robert Torray - Torray Investment Partners
Holding/activity history for Blueprint Medicines (BPMC)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | 0 | 0.00 | Sell 100.00% | 0.31 | SEC | ||
| 2025 Q2 | 16,615 | 0.31 | Reduce 0.38% | <0.01 | $128.18 | $2,129,711 | SEC |
| 2025 Q1 | 16,679 | 0.22 | Add 1.09% | <0.01 | $88.51 | $1,476,258 | SEC |
| 2024 Q4 | 16,499 | 0.21 | Add 1.14% | <0.01 | $87.22 | $1,439,043 | SEC |
| 2024 Q3 | 16,313 | 0.21 | Add 0.44% | <0.01 | $92.50 | $1,508,953 | SEC |
| 2024 Q2 | 16,242 | 0.26 | Reduce 16.36% | 0.05 | $107.78 | $1,750,563 | SEC |
| 2024 Q1 | 19,420 | 0.28 | Add 0.96% | <0.01 | $94.86 | $1,842,181 | SEC |
| 2023 Q4 | 19,235 | 0.29 | Reduce 22.41% | 0.05 | $92.24 | $1,774,236 | SEC |
| 2023 Q3 | 24,791 | 0.22 | Add 4.43% | <0.01 | $50.22 | $1,245,004 | SEC |
| 2023 Q2 | 23,740 | 0.26 | Add 0.58% | <0.01 | $63.20 | $1,500,368 | SEC |
| 2023 Q1 | 23,603 | 0.19 | Add 0.71% | <0.01 | $44.99 | $1,061,899 | SEC |
| 2022 Q4 | 23,436 | 0.18 | Add 34.02% | 0.05 | $43.81 | $1,026,731 | SEC |
| 2022 Q3 | 17,487 | 0.23 | Add 15.32% | 0.03 | $65.88 | $1,152,000 | SEC |
| 2022 Q2 | 15,164 | 0.15 | Add 21.42% | 0.03 | $50.51 | $766,000 | SEC |
| 2022 Q1 | 12,489 | 0.13 | Add 7.94% | <0.01 | $63.90 | $798,000 | SEC |
| 2021 Q4 | 11,570 | 0.18 | Reduce 27.41% | 0.07 | $107.09 | $1,239,000 | SEC |
| 2021 Q3 | 15,938 | 0.25 | Add 34.51% | 0.06 | $102.84 | $1,639,000 | SEC |
| 2021 Q2 | 11,849 | 0.15 | Add 2.98% | <0.01 | $87.94 | $1,042,000 | SEC |
| 2021 Q1 | 11,506 | 0.18 | Buy | 0.18 | $97.25 | $1,119,000 | SEC |